Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ribokinase, putative | 0.0318 | 0.0468 | 1 |
Entamoeba histolytica | kinase, PfkB family | 0.0318 | 0.0468 | 0.5 |
Mycobacterium ulcerans | fructokinase, PfkB | 0.0318 | 0.0468 | 0.5 |
Brugia malayi | Ribokinase | 0.0318 | 0.0468 | 0.0468 |
Leishmania major | putative PfkB family sugar kinase | 0.0318 | 0.0468 | 0.0468 |
Onchocerca volvulus | 0.0318 | 0.0468 | 0.0534 | |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0196 | 0 | 0.5 |
Entamoeba histolytica | tagatose-6-phosphate kinase, putative | 0.0318 | 0.0468 | 0.5 |
Schistosoma mansoni | adenosine kinase | 0.2789 | 1 | 1 |
Onchocerca volvulus | 0.2472 | 0.8774 | 1 | |
Onchocerca volvulus | Ribokinase homolog | 0.0318 | 0.0468 | 0.0534 |
Echinococcus granulosus | adenosine kinase | 0.2789 | 1 | 1 |
Mycobacterium tuberculosis | Adenosine kinase | 0.0318 | 0.0468 | 0.5 |
Toxoplasma gondii | kinase, pfkB family protein | 0.2789 | 1 | 1 |
Schistosoma mansoni | adenosine kinase | 0.2789 | 1 | 1 |
Trypanosoma cruzi | adenosine kinase, putative | 0.2789 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2789 | 1 | 1 |
Trypanosoma cruzi | adenosine kinase, putative | 0.2789 | 1 | 1 |
Mycobacterium tuberculosis | 6-phosphofructokinase PfkB (phosphohexokinase) (phosphofructokinase) | 0.0318 | 0.0468 | 0.5 |
Leishmania major | ribokinase, putative | 0.0318 | 0.0468 | 0.0468 |
Brugia malayi | hypothetical protein | 0.0318 | 0.0468 | 0.0468 |
Mycobacterium leprae | Probable adenosine kinase adk | 0.0318 | 0.0468 | 0.5 |
Leishmania major | tagatose-6-phosphate kinase-like protein | 0.0318 | 0.0468 | 0.0468 |
Schistosoma mansoni | hypothetical protein | 0.1743 | 0.5966 | 0.5966 |
Leishmania major | adenosine kinase-like protein | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma brucei | unspecified product | 0.0236 | 0.0152 | 0.0152 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0196 | 0 | 0.5 |
Trypanosoma brucei | adenosine kinase, putative | 0.2789 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.0468 | 1 |
Leishmania major | adenosine kinase, putative | 0.2789 | 1 | 1 |
Mycobacterium tuberculosis | Ribokinase RbsK | 0.0318 | 0.0468 | 0.5 |
Toxoplasma gondii | kinase, pfkB family protein | 0.0318 | 0.0468 | 0.0468 |
Leishmania major | adenosine kinase-like protein | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma brucei | ribokinase, putative | 0.0318 | 0.0468 | 0.0468 |
Echinococcus granulosus | ribokinase | 0.0318 | 0.0468 | 0.0468 |
Giardia lamblia | Ribokinase | 0.0318 | 0.0468 | 1 |
Schistosoma mansoni | ribokinase | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma brucei | ribokinase, putative | 0.0318 | 0.0468 | 0.0468 |
Trichomonas vaginalis | ribokinase, putative | 0.0318 | 0.0468 | 1 |
Onchocerca volvulus | Putative pyridoxal kinase | 0.0318 | 0.0468 | 0.0534 |
Entamoeba histolytica | ribokinase, putative | 0.0318 | 0.0468 | 0.5 |
Trichomonas vaginalis | ribokinase, putative | 0.0318 | 0.0468 | 1 |
Echinococcus granulosus | pseudouridine metabolizing bifunctional protein | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0236 | 0.0152 | 0.0152 |
Echinococcus multilocularis | ribokinase | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0236 | 0.0152 | 0.0152 |
Trypanosoma brucei | RNA helicase, putative | 0.1743 | 0.5966 | 0.5966 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0318 | 0.0468 | 0.0468 |
Entamoeba histolytica | fructokinase, putative | 0.0318 | 0.0468 | 0.5 |
Trypanosoma brucei | adenosine kinase, putative | 0.2789 | 1 | 1 |
Mycobacterium ulcerans | carbohydrate kinase CbhK | 0.0318 | 0.0468 | 0.5 |
Echinococcus multilocularis | pseudouridine metabolizing bifunctional protein | 0.0318 | 0.0468 | 0.0468 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0236 | 0.0152 | 0.0152 |
Leishmania major | tagatose-6-phosphate kinase-like protein | 0.0318 | 0.0468 | 0.0468 |
Entamoeba histolytica | Hypothetical protein T24C12.3, putative | 0.0318 | 0.0468 | 0.5 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0236 | 0.0152 | 0.0152 |
Echinococcus multilocularis | adenosine kinase | 0.2789 | 1 | 1 |
Trypanosoma cruzi | ribokinase, putative | 0.0318 | 0.0468 | 0.0468 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.